Bactrim Dosage for MRSA Wound Infection
For MRSA wound infections in adults with normal renal function, use trimethoprim-sulfamethoxazole (TMP-SMX) 1-2 double-strength tablets (160/800 mg) twice daily for 7-14 days, with the higher dose (2 DS tablets = 320/1600 mg twice daily) preferred for more extensive or severe infections. 1
Adult Dosing Recommendations
Standard dosing for purulent cellulitis or uncomplicated MRSA wound infections:
- 1-2 double-strength (DS) tablets orally twice daily 1
- Each DS tablet contains 160 mg trimethoprim and 800 mg sulfamethoxazole 1
- The higher dose (2 DS tablets = 320/1600 mg BID) is recommended for more serious infections 2
Treatment duration:
- 7-14 days depending on infection severity and clinical response 1, 3
- Simple infections may require only 5-10 days 3
- More complicated infections warrant the full 14-day course 1, 3
Pediatric Dosing
For children, dose based on the trimethoprim component:
- Trimethoprim 4-6 mg/kg/dose, sulfamethoxazole 20-30 mg/kg/dose orally every 12 hours 1
- Contraindicated in children under 2 months of age 1
Evidence Quality and Context
The IDSA guidelines provide Level AII evidence supporting TMP-SMX for MRSA skin and soft tissue infections 1. Research comparing standard dose (160/800 mg BID) versus high dose (320/1600 mg BID) found similar clinical resolution rates (75% vs 73%), suggesting either dose is effective, though guidelines favor the higher dose for serious infections 4. A randomized trial demonstrated TMP-SMX achieved 91.9% cure rates for uncomplicated wound infections, comparable to clindamycin 5.
Critical Caveats and Pitfalls
Streptococcal coverage limitation:
- TMP-SMX has poor activity against beta-hemolytic streptococci 1
- If streptococcal coverage is needed (non-purulent cellulitis), combine with a beta-lactam (amoxicillin or cephalexin) or use clindamycin instead 1, 3
When antibiotics are actually needed:
- For simple abscesses, incision and drainage alone may be adequate without antibiotics 1, 3
- Add antibiotics if: severe/extensive disease, rapid progression, systemic illness signs, comorbidities/immunosuppression, extremes of age, difficult-to-drain locations, septic phlebitis, or failure of drainage alone 1, 3
Pregnancy and allergy considerations:
Monitoring Requirements
- Monitor renal function with prolonged therapy 2
- Watch for hypersensitivity reactions 2
- Assess clinical response at 7-14 days to determine if treatment extension is needed 1
Alternative Agents When TMP-SMX Cannot Be Used
If TMP-SMX is contraindicated or ineffective: